CEACAM5 and cancer: We designed two novel TCEs by linking a scFv that recognizes CD3ε on either murine T cells (αCEA:mCD3) or human T cells (αCEA:hCD3) to a His-tagged scFv that binds human CEACAM5 on the surface of cancer cells (Figure 1A; Supplementary Figure 1A).